5th Annual Monoclonal Antibodies Conference: March 24–25, 2009, London, UK
FONTE
Landes Bioscience
RESUMO
The conference, which was organized by Visiongain and held at the BSG Conference Center in London, provided an excellent opportunity for participants to exchange views on the development, production and marketing of therapeutic antibodies, and discuss the current business environment. The conference included numerous interactive panel and group discussions on topics such as isotyping for therapeutic antibodies (panel chair: Nick Pullen, Pfizer), prospects for fully human monoclonal antibodies (chair: Christian Rohlff, Oxford BioTherapeutics), perspectives on antibody manufacturing and development (chair: Bo Kara, Avecia), market impact and post-marketing issues (chair: Keith Rodgers, Bodiam Consulting) and angiogenesis inhibitors (chair: David Blakey, AstraZeneca).
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2726607Documentos Relacionados
- European Medicines Agency workshop on biosimilar monoclonal antibodies July 2, 2009, London, UK
- SOCIETY FOR SOCIAL MEDICINE: XIV ANNUAL MEETING, SEPTEMBER 24-25, 1970, University of Newcastle upon Tyne
- Proceedings of the Association of British Neurologists, Royal College of Physicians, London, 24-25 September 1992
- 5th European Conference on Microcirculation
- Conference on gene therapy, Royal College of Physicians, London, 1 March 1990.
